Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.30 | -$0.28 | -$0.29 |
| Q2 2026 | 2 | -$0.28 | -$0.26 | -$0.27 |
| Q3 2026 | 1 | -$0.24 | -$0.22 | -$0.23 |
| Q4 2026 | 1 | -$0.21 | -$0.20 | -$0.20 |
| Q1 2027 | 1 | $0.08 | $0.08 | $0.08 |
| Q2 2027 | 1 | $0.11 | $0.11 | $0.11 |
| Q3 2027 | 1 | $0.13 | $0.14 | $0.13 |
| Q4 2027 | 1 | $0.12 | $0.13 | $0.12 |
| Q1 2028 | 1 | $0.21 | $0.23 | $0.22 |
| Q2 2028 | 1 | $0.25 | $0.27 | $0.26 |
| Q3 2028 | 1 | $0.26 | $0.28 | $0.27 |
| Q4 2028 | 1 | $0.25 | $0.27 | $0.26 |
AVITA Medical Inc last posted its earnings results on Thursday, February 12th, 2026. The company reported $-0.38 earnings per share for the quarter, missing analysts' consensus estimates of $-0.36444 by $0.01556. The company had revenue of 17.62 M for the quarter and had revenue of 71.61 M for the year. AVITA Medical Inc has generated $-2 earnings per share over the last year ($-1.74 diluted earnings per share) and currently has a price-to-earnings ratio of -2.77. AVITA Medical Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 2025 | -$0.36 | -$0.38 | -0.02 | $17.84 M | $17.62 M |
| 11/06/2025 | Q3 2025 | -$0.43 | -$0.46 | -0.03 | $18.37 M | $17.06 M |
| 08/07/2025 | Q2 2025 | N/A | -$0.38 | N/A | $22.51 M | $18.42 M |
| 05/08/2025 | Q1 2025 | -$0.39 | -$0.53 | -0.14 | $20.75 M | $18.51 M |
| 02/13/2025 | Q4 2024 | -$0.30 | -$0.44 | -0.14 | $20.72 M | $18.41 M |
| 11/07/2024 | Q3 2024 | -$0.42 | -$0.62 | -0.2 | $19.44 M | $19.55 M |
| 08/08/2024 | Q2 2024 | -$0.59 | -$0.60 | -0.01 | $14.52 M | $15.20 M |
| 05/13/2024 | Q1 2024 | -$0.26 | -$0.73 | -0.47 | $11.08 M | $11.10 M |
| 02/22/2024 | Q4 2023 | -$0.34 | -$0.28 | 0.06 | N/A | $14.20 M |
| 11/09/2023 | Q3 2023 | -$0.53 | -$0.53 | 0 | N/A | $13.65 M |
| 08/10/2023 | Q2 2023 | -$0.34 | -$0.62 | -0.28 | N/A | $11.75 M |
| 05/11/2023 | Q1 2023 | -$0.22 | -$0.55 | -0.33 | N/A | $10.55 M |
| 02/23/2023 | Q4 2022 | -$0.32 | -$0.31 | 0.01 | N/A | $9.46 M |
| 11/10/2022 | Q3 2022 | -$0.32 | -$0.35 | -0.03 | N/A | $9.09 M |
| 08/11/2022 | Q2 2022 | -$0.35 | -$0.36 | -0.01 | N/A | $8.34 M |
| 05/12/2022 | Q1 2022 | -$0.36 | -$0.51 | -0.15 | N/A | $7.54 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.25 | N/A | N/A | $6.94 M |
| 11/08/2021 | Q3 2021 | -$0.40 | -$0.24 | 0.16 | N/A | $7.02 M |
| 08/26/2021 | Q2 2021 | -$0.32 | -$0.19 | 0.13 | N/A | $10.30 M |
| 05/13/2021 | Q1 2021 | -$0.38 | -$0.35 | 0.03 | N/A | $8.77 M |
The conference call for AVITA Medical Inc's latest earnings report can be listened to online.
The conference call transcript for AVITA Medical Inc's latest earnings report can be read online.
AVITA Medical Inc (:RCEL) has a recorded annual revenue of $71.61 M.
AVITA Medical Inc (:RCEL) has a recorded net income of $-48,587,000.AVITA Medical Inc has generated $-1.74 earnings per share over the last four quarters.
AVITA Medical Inc (:RCEL) has a price-to-earnings ratio of -2.77 and price/earnings-to-growth ratio is -0.08.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED